These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 20224387)
1. Risk stratification of ventricular arrhythmias in patients with systolic heart failure. Vest RN; Gold MR Curr Opin Cardiol; 2010 May; 25(3):268-75. PubMed ID: 20224387 [TBL] [Abstract][Full Text] [Related]
2. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy. Chauhan VS; Selvaraj RJ Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041 [TBL] [Abstract][Full Text] [Related]
3. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator. Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232 [TBL] [Abstract][Full Text] [Related]
4. Microvolt T-wave alternans for the risk stratification of dangerous ventricular arrhythmias in patients with previously implanted automatic cardioverter-defibrillator. Lewandowski M; Kossuth I; Zielonka J; Wielusiński M; Kazimierczak A; Kornacewicz Jach Z; Przybycień K; Kaliszczak R Kardiol Pol; 2011; 69(6):580-5. PubMed ID: 21678296 [TBL] [Abstract][Full Text] [Related]
5. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? Dagres N; Hindricks G Eur Heart J; 2013 Jul; 34(26):1964-71. PubMed ID: 23644180 [TBL] [Abstract][Full Text] [Related]
6. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU; Goldenberg I; Moss AJ Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691 [TBL] [Abstract][Full Text] [Related]
7. Predictive power of T-wave alternans and of ventricular gradient hysteresis for the occurrence of ventricular arrhythmias in primary prevention cardioverter-defibrillator patients. Man S; De Winter PV; Maan AC; Thijssen J; Borleffs CJ; van Meerwijk WP; Bootsma M; van Erven L; van der Wall EE; Schalij MJ; Burattini L; Burattini R; Swenne CA J Electrocardiol; 2011; 44(4):453-9. PubMed ID: 21704222 [TBL] [Abstract][Full Text] [Related]
8. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS; J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603 [TBL] [Abstract][Full Text] [Related]
10. [Arrhythmia risk stratification in patients with heart failure. Foreword]. Opasich C; Santini M Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345 [TBL] [Abstract][Full Text] [Related]
11. Sudden cardiac death in heart failure. Klein L; Hsia H Cardiol Clin; 2014 Feb; 32(1):135-44, ix. PubMed ID: 24286584 [TBL] [Abstract][Full Text] [Related]
12. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Gold MR; Ip JH; Costantini O; Poole JE; McNulty S; Mark DB; Lee KL; Bardy GH Circulation; 2008 Nov; 118(20):2022-8. PubMed ID: 18955671 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Grimm W; Christ M; Bach J; Müller HH; Maisch B Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812 [TBL] [Abstract][Full Text] [Related]
14. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death. Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211 [TBL] [Abstract][Full Text] [Related]
15. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study. Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545 [TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307 [TBL] [Abstract][Full Text] [Related]
17. Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification. Piepoli MF; Capucci A Minerva Cardioangiol; 2007 Jun; 55(3):325-33. PubMed ID: 17534251 [TBL] [Abstract][Full Text] [Related]
18. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk]. Lombardi F Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310 [TBL] [Abstract][Full Text] [Related]